Top Button
Benjamin (Ben) Oster is an associate in Ice Miller’s Business Group. He focuses his practice on transactional matters and has extensive experience working with organizations in emerging industries, technologies and sciences.

Prior to joining Ice Miller, Ben was a business associate at Cleveland Clinic Innovations within the Cleveland Clinic hospital system where he was involved in a number of ventures, including licensing of Cleveland Clinic intellectual property to biomed- and biopharma-based companies ranging in size from start-ups to well-established, large manufacturers and distributors. Ben also worked with several early-stage Cleveland Clinic spin-off companies. Ben assisted team members in structuring deals, corporate and commercial transactions and education.

Ben was previously an associate at a boutique law firm in San Francisco that specialized in emerging-growth company transactions. In this role, Ben assisted in guiding multiple start-up and emerging-companies through various business concerns, from formation to capital raising.

Ben was a summer scholar in the Industrial Partnerships Office at Lawrence Livermore National Laboratory (LLNL), a federally funded national security laboratory in Livermore, California. While at LLNL, he assisted on a number of software and high-tech/high-R&D transactional issues.

Ben earned his Master of Science in biotechnology (focusing on biochemistry and molecular and cellular biology) from the Georgetown University Graduate School of Arts & Sciences in 2014. The year prior, he earned his LL.M. from the Duke University School of Law, where he focused his work on early-stage corporate transactions.

In 2012, Ben earned his juris doctor, cum laude, from the Case Western Reserve University School of Law, including concentrations with honors in corporate law and health law. During law school, he served as a research assistant to several professors and as an editor on the Journal of International Law. He received his Bachelor of Science in financial management from The Ohio State University in 2005.

Benjamin is licensed to practice law in the state of Ohio.
 
Representative Transactions
  • Assisted with representation of distributor and retailer in $3.5 million seed funding
  • Assisted with representation of distributor and retailer in $2.4 million seed funding
  • Assisted with representation of distributor and retailer in $2.3 million seed funding
  • Assisted with representation of telemedicine provider in cure of $1 million improper private placement
  • Assisted with representation and advisement of multiple companies on entity formation.
  • Led drafting of trade secret license for a biologic grafting manufacturer
  • Assisted with drafting and closing master collaboration deal with large, well-respected Japanese electronics manufacturer for medical device development
  • Led negotiation and drafting of joint development and data license agreement with AI-based start-up for development of an artificial intelligence in health care IP
  • Assisted with or led several additional transactions in health IT, therapeutics & diagnostics and medical device licensing and R&D collaboration that included firms operating in large scale medical supply distribution, machine-to-machine cloud platform services, decision support software, virtual reality/augmented reality, lighting devices, cryogenic devices, exercise and physical therapy equipment, education, orthopedics, general medical device engineering, biopharmaceuticals and biotech and general international R&D
News
Published In
  • Co-author, “The Proactive Patient: LTC Insurance Discrimination Risks of Alzheimer’s Biomarkers,” 46 J. L. Med & Ethics 485, 2018.
View Full Site View Mobile Optimized